149 related articles for article (PubMed ID: 24781450)
1. Hypertriglyceridemia and hyperglycemia induced by capecitabine: a report of two cases and review of the literature.
Han GH; Huang JX
J Oncol Pharm Pract; 2015 Oct; 21(5):380-3. PubMed ID: 24781450
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine-induced hypertriglyceridemia: a report of two cases.
Koutras AK; Habeos IG; Vagenakis AG; Kalofonos HP
Anticancer Res; 2006; 26(3B):2249-51. PubMed ID: 16821596
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.
Duman BB; Paydas S; Tetiker T; Gunaldı M; Afsar CU; Erçolak V; Haksöyler V; Dilli MŞ
Pharmacology; 2012; 90(3-4):212-5. PubMed ID: 23038659
[TBL] [Abstract][Full Text] [Related]
5. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
Bar-Sela G; Haim N
Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
Seminara P; Losanno T; Emiliani A; Manna G
Cardiology; 2010; 116(1):42-4. PubMed ID: 20431291
[TBL] [Abstract][Full Text] [Related]
7. Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine.
Geva S; Lazarev I; Geffen DB; Ariad S
J Chemother; 2013 Jun; 25(3):176-80. PubMed ID: 23783143
[TBL] [Abstract][Full Text] [Related]
8. Increase in triglyceride blood level in patients treated with capecitabine: a retrospective survey.
Bar-Sela G; Cohensius-Kent D; Vornikova O; Haim N
Anticancer Drugs; 2014 Jul; 25(6):729-34. PubMed ID: 24595094
[TBL] [Abstract][Full Text] [Related]
9. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
[TBL] [Abstract][Full Text] [Related]
10. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
Santini D; Vincenzi B; Schiavon G; Di Seri M; Virzí V; Spalletta B; Caricato M; Coppola R; Tonini G
Cancer Chemother Pharmacol; 2007 Apr; 59(5):613-20. PubMed ID: 16944151
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
Comella P; Natale D; Farris A; Gambardella A; Maiorino L; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S; Cannone M
Cancer; 2005 Jul; 104(2):282-9. PubMed ID: 15948167
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine?
Chan HY; Ng CM; Tiu SC; Chan AO; Shek CC
Hong Kong Med J; 2012 Dec; 18(6):526-9. PubMed ID: 23223655
[TBL] [Abstract][Full Text] [Related]
13. The clinical importance of recognizing capecitabine-induced hypertriglyceridemia: A case report and review of the literature.
Leung J; Brady JL; Crook MA
J Clin Lipidol; 2018; 12(6):1371-1373. PubMed ID: 30126762
[TBL] [Abstract][Full Text] [Related]
14. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
Cassidy J; Tabernero J; Twelves C; Brunet R; Butts C; Conroy T; Debraud F; Figer A; Grossmann J; Sawada N; Schöffski P; Sobrero A; Van Cutsem E; Díaz-Rubio E
J Clin Oncol; 2004 Jun; 22(11):2084-91. PubMed ID: 15169795
[TBL] [Abstract][Full Text] [Related]
15. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Simkens LH; van Tinteren H; May A; ten Tije AJ; Creemers GJ; Loosveld OJ; de Jongh FE; Erdkamp FL; Erjavec Z; van der Torren AM; Tol J; Braun HJ; Nieboer P; van der Hoeven JJ; Haasjes JG; Jansen RL; Wals J; Cats A; Derleyn VA; Honkoop AH; Mol L; Punt CJ; Koopman M
Lancet; 2015 May; 385(9980):1843-52. PubMed ID: 25862517
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
17. Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer.
Farid M; Chowbay B; Chen X; Tan SH; Ramasamy S; Koo WH; Toh HC; Choo SP; Ong SY
Cancer Chemother Pharmacol; 2012 Jul; 70(1):141-50. PubMed ID: 22648745
[TBL] [Abstract][Full Text] [Related]
18. [Tolerability of XELOX in postoperative adjuvant chemotherapy for colorectal cancer].
Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Kawada J; Takagi M; Fukui A; Iwase K; Tanaka Y
Gan To Kagaku Ryoho; 2014 Jun; 41(6):743-7. PubMed ID: 25129086
[TBL] [Abstract][Full Text] [Related]
19. FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer.
Petrioli R; Paolelli L; Marsili S; Civitelli S; Francini E; Cioppa T; Roviello F; Nettuno R; Intrivici C; Tanzini G; Lorenzi M; Francini G
Oncology; 2006; 70(5):345-50. PubMed ID: 17179728
[TBL] [Abstract][Full Text] [Related]
20. A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Comella P; Gambardella A; Farris A; Maiorino L; Natale D; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S;
Crit Rev Oncol Hematol; 2005 Feb; 53(2):133-9. PubMed ID: 15661564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
